Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maike
Maike Dahle, Lage-Waddenhausen DE
| Patent application number | Description | Published |
|---|---|---|
| 20120059075 | HYBRID FOAM - The invention relates to highly elastic polyurethane foams which are suitable as functional materials having thermally insulating properties. | 03-08-2012 |
Maike Glien, Wiesbaden DE
| Patent application number | Description | Published |
|---|---|---|
| 20080255212 | OXADIAZOLONES AND DERIVATIVES THEREOF AS PEROXISOME PROLIFERATOR - ACTIVATED RECEPTOR (PPAR) DELTA AGONISTS - The invention relates to oxadiazolones and to their physiologically acceptable salts and physiologically functional derivatives showing peroxisome proliferator activator receptor (PPAR) delta agonist activity comprising compounds of formula I, | 10-16-2008 |
| 20080262052 | METHODS FOR THE TREATMENT OF METABOLIC AND GLUCOSE UTILIZATION DISORDERS THROUGH THE ADMINISTRATION OF OXADIAZOLONES AND DERIVATIVES THEREOF AS PEROXISOME PROLIFERATOR - ACTIVATED RECEPTOR (PPAR) DELTA AGONISTS - The invention relates to oxadiazolones and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. | 10-23-2008 |
| 20090281084 | PHENYL-1,2,4-OXADIAZOLONE DERIVATIVES WITH PHENYL GROUP, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS - The invention relates to phenyl-1,2,4-oxadiazolone derivatives with phenyl group and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta agonist activity. | 11-12-2009 |
| 20090298871 | SULFONYL-PHENYL-2H-[1,2,4]OXADIAZOL-5-ONE DERIVATIVES , PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PHARMACEUTICALS - The invention relates to sulfonyl-phenyl-oxadiazolones and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta or PPARdelta and PPARgamma agonist activity. | 12-03-2009 |
| 20100022603 | BICYCLIC ARYL-SULFONIC ACID [1,3,4]-THIADIAZOL-2-YL-AMIDES, PROCESSES FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USE - The present invention comprises bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, their functional derivatives thereof as well as their physiologically acceptable salts and pharmaceutical compositions thereof that exhibit peroxisome proliferator activated receptor (PPAR) PPARdelta and PPARgamma agonist activity. The structure of the compounds of the invention are defined by Formula I below, | 01-28-2010 |
| 20110224263 | Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals - The invention relates to cyclic N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides and to their physiologically acceptable salts and physiologically functional derivatives showing PPARdelta or PPARdelta and PPARgamma agonist activity. | 09-15-2011 |
Maike Hillers, Paris FR
| Patent application number | Description | Published |
|---|---|---|
| 20110131889 | BONDED ABRASIVE ARTICLE AND METHOD OF FORMING - An abrasive article including an abrasive body having abrasive grains made of microcrystalline alumina contained within a bond material, wherein the bond material comprises a total content of alumina of at least about 15 mol %. | 06-09-2011 |
Maike Ihnen, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110033852 | PRESENT INVENTION RELATES TO METHODS FOR PREDICTION OF THE THERAPEUTIC SUCCESS OF BREAST CANCER THERAPY - The present invention relates to a method for predicting a clinical response of a patient suffering from or at risk of developing gynecologic cancer towards a given mode of treatment, said method comprising the steps of: a) obtaining a biological sample from said patient; b) determining the expression level of at least one gene selected from the group comprising ALCAM, Osteopontin, Her-2/neu, EGFR, uPA/PAI-1 and/or ESR1, in particular of ALCAM and/or Osteopontin, in said sample; c) comparing the pattern of expression level (s) determined in (b) with one or several reference pattern (s) of expression levels; and d) predicting therapeutic success for said given mode of treatment in said patient or implementing therapeutic regimen in said patient from the outcome of the comparison in step (c). | 02-10-2011 |
Maike Löhndorf, Wien AT
| Patent application number | Description | Published |
|---|---|---|
| 20100283856 | Method For Calibrating The Image Of A Camera - A method for calibrating the image ( | 11-11-2010 |
Maike Wiesenfarth, Freiburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110265852 | OPEN ENCAPSULATED CONCENTRATOR SYSTEM FOR SOLAR RADIATION - The invention relates to an open concentrator system for solar radiation comprising a hollow mirror and a photovoltaic module comprising a plurality of solar cells disposed in the focus of said hollow mirror, the photovoltaic module being encapsulated by a housing. The housing is thereby configured such that it has a transparent cover at least in the region of the incident radiation reflected by the hollow mirror and such that this transparent cover is at a spacing from photovoltaic module, i.e. is situated in the cone of the incident radiation. | 11-03-2011 |